China Pharma Holdings (CPHI) Operating Leases (2019 - 2026)

China Pharma Holdings (CPHI) posted Operating Leases of $92294.0 for Q1 2026, down 17.26% on a QoQ basis from $111548.0 in Q4 2025.

China Pharma Holdings (CPHI) Operating Leases (2019 - 2026) Analysis & Trends

China Pharma Holdings' Operating Leases history runs 8 years deep, the most recent figure standing at $92294.0 for Q1 2026.

  • Quarterly Operating Leases changed N/A year-over-year to $92294.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92294.0 (changed N/A YoY) and the FY2025 annual result came in at $111548.0, up 183.67% from the prior year.
  • Operating Leases was $92294.0 for Q1 2026 at China Pharma Holdings, down from $111548.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $198583.0 in Q3 2025 and bottomed at $20008.0 in Q1 2024.
  • A 5-year average of $84695.0 and a median of $82959.0 in 2022 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2022 — Operating Leases surged 307.55% — and 2023, when it plunged 81.08%.
  • China Pharma Holdings' Operating Leases stood at $40445.0 in 2022, then retreated by 1.32% to $39910.0 in 2023, then dropped by 1.47% to $39323.0 in 2024, then soared by 183.67% to $111548.0 in 2025, then declined by 17.26% to $92294.0 in 2026.
  • Business Quant data shows CPHI's Operating Leases at $92294.0 in Q1 2026, $111548.0 in Q4 2025, and $198583.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 China Pharma Holdings 629,344.02 460,870.02 285,487.00

Historic Data

Download Data
DateValue
Mar 31, 2026 92,294.00
Dec 31, 2025 111,548.00
Sep 30, 2025 198,583.00
Dec 31, 2024 39,323.00
Mar 31, 2024 20,008.00
Dec 31, 2023 39,910.00
Sep 30, 2023 134,794.00
Jun 30, 2023 152,401.00
Mar 31, 2023 20,617.00
Dec 31, 2022 40,445.00
Sep 30, 2022 59,163.00
Jun 30, 2022 82,959.00
Mar 31, 2022 108,990.00
Dec 31, 2021 44,181.00
Sep 30, 2021 64,767.00
Jun 30, 2021 86,186.00
Mar 31, 2021 26,743.00
Dec 31, 2020 52,070.00
Sep 30, 2020 73,690.00
Jun 30, 2020 93,510.00